Published in Exp Neurol on March 01, 1996
Inflammation and Alzheimer's disease. Neurobiol Aging (2000) 12.56
The role of the anaphylatoxins in health and disease. Mol Immunol (2009) 2.95
A review: inflammatory process in Alzheimer's disease, role of cytokines. ScientificWorldJournal (2012) 2.03
Toxicity from different SOD1 mutants dysregulates the complement system and the neuronal regenerative response in ALS motor neurons. Proc Natl Acad Sci U S A (2007) 1.79
Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease. Am J Pathol (2001) 1.66
Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease. J Immunol (2009) 1.66
Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer's disease mice. J Neuroinflammation (2005) 1.64
Up-regulated production and activation of the complement system in Alzheimer's disease brain. Am J Pathol (1999) 1.60
Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease. ASN Neuro (2010) 1.58
Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study. J Neuroinflammation (2012) 1.57
TGF-β signaling regulates neuronal C1q expression and developmental synaptic refinement. Nat Neurosci (2013) 1.56
The complement cascade: Yin-Yang in neuroinflammation--neuro-protection and -degeneration. J Neurochem (2008) 1.48
Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer's disease. J Neurochem (2008) 1.45
Complement in the brain. Mol Immunol (2011) 1.41
Microglia, Alzheimer's disease, and complement. Int J Alzheimers Dis (2012) 1.21
Microglial C5aR (CD88) expression correlates with amyloid-beta deposition in murine models of Alzheimer's disease. J Neurochem (2010) 1.16
Temporal accrual of complement proteins in amyloid plaques in Down's syndrome with Alzheimer's disease. Am J Pathol (2000) 1.13
Frontal cortex neuropathology in dementia pugilistica. J Neurotrauma (2012) 1.08
Expression of complement system components during aging and amyloid deposition in APP transgenic mice. J Neuroinflammation (2009) 1.04
Microglia receptors and their implications in the response to amyloid β for Alzheimer's disease pathogenesis. J Neuroinflammation (2014) 1.03
Contribution of complement activation pathways to neuropathology differs among mouse models of Alzheimer's disease. J Neuroinflammation (2011) 1.02
Apolipoprotein E isoforms and regulation of the innate immune response in brain of patients with Alzheimer's disease. Curr Opin Neurobiol (2011) 1.01
Induction of complement proteins in a mouse model for cerebral microvascular A beta deposition. J Neuroinflammation (2007) 0.94
Differential regulation of Abeta42-induced neuronal C1q synthesis and microglial activation. J Neuroinflammation (2005) 0.85
Complement protein C1q modulates neurite outgrowth in vitro and spinal cord axon regeneration in vivo. J Neurosci (2015) 0.84
From development to dysfunction: microglia and the complement cascade in CNS homeostasis. Ageing Res Rev (2013) 0.83
Complement activation fragment C5a receptors, CD88 and C5L2, are associated with neurofibrillary pathology. J Neuroinflammation (2013) 0.79
White matter injury due to experimental chronic cerebral hypoperfusion is associated with C5 deposition. PLoS One (2013) 0.79
What does complement do in Alzheimer's disease? Old molecules with new insights. Transl Neurodegener (2013) 0.79
Molecular Dissection of Cyclosporin A's Neuroprotective Effect Reveals Potential Therapeutics for Ischemic Brain Injury. Brain Sci (2013) 0.78
Microglial complement receptor 3 regulates brain Aβ levels through secreted proteolytic activity. J Exp Med (2017) 0.75
Interactions between inflammation, sex steroids, and Alzheimer's disease risk factors. Front Neuroendocrinol (2016) 0.75
C5a Increases the Injury to Primary Neurons Elicited by Fibrillar Amyloid Beta. ASN Neuro (2017) 0.75
Analysis of the Putative Role of CR1 in Alzheimer's Disease: Genetic Association, Expression and Function. PLoS One (2016) 0.75
Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss. Mol Neurodegener (2017) 0.75
A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med (1997) 7.56
Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease. Neurobiol Aging (1997) 5.66
Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J Neurosci (1993) 4.60
The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol (1989) 4.21
Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. JAMA (2000) 3.99
In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res (1991) 3.45
Physical activity increases mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain. Brain Res (1996) 3.18
Clinical and pathological evidence for a frontal variant of Alzheimer disease. Arch Neurol (1999) 3.03
Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease. Neurology (1991) 2.77
Purification and radiolabeling of human C1q. J Immunol (1981) 2.75
Measurement of free electrophoretic mobility and retardation coefficient of protein-sodium dodecyl sulfate complexes by gel electrophoresis. A method to validate molecular weight estimates. J Biol Chem (1972) 2.73
Distribution of N-methyl-D-aspartate-sensitive L-[3H]glutamate-binding sites in rat brain. J Neurosci (1985) 2.66
Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci U S A (1993) 2.62
Synaptic proteins. Characterization of tubulin and actin and identification of a distinct postsynaptic density polypeptide. J Cell Biol (1978) 2.44
Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res (1990) 2.26
Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity. J Neurochem (1995) 2.24
Apolipoprotein-E genotyping of diabetic dementia patients: is diabetes rare in Alzheimer's disease? J Am Geriatr Soc (1996) 2.23
Long-term potentiation in the hippocampus involves activation of N-methyl-D-aspartate receptors. Brain Res (1984) 2.21
Protease nexin-II, a potent antichymotrypsin, shows identity to amyloid beta-protein precursor. Nature (1989) 2.17
Whose utilities for decision analysis? Med Decis Making (1990) 2.12
Survival and growth of hippocampal neurons in defined medium at low density: advantages of a sandwich culture technique or low oxygen. Brain Res (1989) 2.12
Characterization of C1q receptor expression on human phagocytic cells: effects of PDBu and fMLP. J Immunol (1986) 2.09
Does a centralized radiotherapy system provide adequate access to care? J Clin Oncol (1997) 1.90
Amino-terminal deletions enhance aggregation of beta-amyloid peptides in vitro. J Biol Chem (1995) 1.89
Synaptic plasma membranes from rat brain synaptosomes: isolation and partial characterization. Biochim Biophys Acta (1971) 1.84
Long-term potentiation of guinea pig mossy fiber responses is not blocked by N-methyl D-aspartate antagonists. Neurosci Lett (1986) 1.83
An analysis of 78 breast sarcoma patients without distant metastases at presentation. Int J Radiat Oncol Biol Phys (2000) 1.82
Beta-amyloid induces local neurite degeneration in cultured hippocampal neurons: evidence for neuritic apoptosis. Neurobiol Dis (1998) 1.81
Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport (1994) 1.81
Isolation of postsynaptic densities from rat brain. J Cell Biol (1974) 1.77
Alzheimer's presenilin-1 mutation potentiates inositol 1,4,5-trisphosphate-mediated calcium signaling in Xenopus oocytes. J Neurochem (1999) 1.71
Amyloid beta protein enhances the survival of hippocampal neurons in vitro. Science (1989) 1.69
Estrogen and exercise interact to regulate brain-derived neurotrophic factor mRNA and protein expression in the hippocampus. Eur J Neurosci (2001) 1.68
Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease. Am J Pathol (2001) 1.66
Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein. Science (1999) 1.65
Anatomical distributions of four pharmacologically distinct 3H-L-glutamate binding sites. Nature (1984) 1.63
Voluntary exercise protects against stress-induced decreases in brain-derived neurotrophic factor protein expression. Neuroscience (2004) 1.63
Isolation and structural studies on synaptic complexes from rat brain. J Cell Biol (1972) 1.63
Exercise primes a molecular memory for brain-derived neurotrophic factor protein induction in the rat hippocampus. Neuroscience (2005) 1.60
Adult paratesticular sarcomas: a review of 21 cases. J Urol (1991) 1.59
cDNA cloning and primary structure analysis of C1qR(P), the human C1q/MBL/SPA receptor that mediates enhanced phagocytosis in vitro. Immunity (1997) 1.58
Learning upregulates brain-derived neurotrophic factor messenger ribonucleic acid: a mechanism to facilitate encoding and circuit maintenance? Behav Neurosci (1998) 1.57
Aggregation-related toxicity of synthetic beta-amyloid protein in hippocampal cultures. Eur J Pharmacol (1991) 1.56
Beta-amyloid increases neuronal susceptibility to injury by glucose deprivation. Neuroreport (1991) 1.55
Effects of exercise on gene-expression profile in the rat hippocampus. Neurobiol Dis (2001) 1.54
Exercise, antidepressant medications, and enhanced brain derived neurotrophic factor expression. Neuropsychopharmacology (1999) 1.52
Kynurenic acid inhibits synaptic and acidic amino acid-induced responses in the rat hippocampus and spinal cord. Brain Res (1983) 1.51
Modulation of FcR function by complement: subcomponent C1q enhances the phagocytosis of IgG-opsonized targets by human monocytes and culture-derived macrophages. J Immunol (1987) 1.51
Image analysis of beta-amyloid load in Alzheimer's disease and relation to dementia severity. Lancet (1995) 1.51
A detailed analysis of hydrogen peroxide-induced cell death in primary neuronal culture. Neuroscience (1995) 1.50
Micromolar L-2-amino-4-phosphonobutyric acid selectively inhibits perforant path synapses from lateral entorhinal cortex. Brain Res (1981) 1.50
Baclofen selectively inhibits excitatory synaptic transmission in the hippocampus. Brain Res (1981) 1.50
A randomized trial of radiation therapy compared to split course radiation therapy combined with mitomycin C and 5 fluorouracil as initial treatment for advanced laryngeal and hypopharyngeal squamous carcinoma. Int J Radiat Oncol Biol Phys (1993) 1.50
Human mannose-binding protein activates the alternative complement pathway and enhances serum bactericidal activity on a mannose-rich isolate of Salmonella. J Clin Invest (1989) 1.47
Physical activity and antidepressant treatment potentiate the expression of specific brain-derived neurotrophic factor transcripts in the rat hippocampus. Neuroscience (2000) 1.47
Plasticity of hippocampal circuitry in Alzheimer's disease. Science (1985) 1.46
Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities. J Neurosci (1997) 1.45
Microlithographic determination of axonal/dendritic polarity in cultured hippocampal neurons. J Neurosci Methods (1998) 1.44
Selective reinnervation of hippocampal area CA1 and the fascia dentata after destruction of CA3-CA4 afferents with kainic acid. Brain Res (1980) 1.44
Combined radiation therapy, mitomycin C, and 5-fluorouracil for locally recurrent rectal carcinoma: results of a pilot study. Int J Radiat Oncol Biol Phys (1991) 1.43
Analysis of receptor-mediated C1q binding to human peripheral blood mononuclear cells. J Immunol (1980) 1.43
Beta -amyloid-(1-42) impairs activity-dependent cAMP-response element-binding protein signaling in neurons at concentrations in which cell survival Is not compromised. J Biol Chem (2001) 1.43
Exercise-induced regulation of brain-derived neurotrophic factor (BDNF) transcripts in the rat hippocampus. Brain Res Mol Brain Res (1998) 1.42
Intraventricular kainic acid preferentially destroys hippocampal pyramidal cells. Nature (1978) 1.42
Seminoma of the testis: results of treatment and patterns of failure after radiation therapy. Int J Radiat Oncol Biol Phys (1982) 1.41
DNA damage and apoptosis in Alzheimer's disease: colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay. J Neurosci (1996) 1.41
Basic fibroblast growth factor prevents death of lesioned cholinergic neurons in vivo. Nature (1988) 1.40
Exercise and time-dependent benefits to learning and memory. Neuroscience (2010) 1.39
Agglutination of plant protoplasts by fungal cell wall glucans. Science (1978) 1.39
Two classes of N-methyl-D-aspartate recognition sites: differential distribution and differential regulation by glycine. Proc Natl Acad Sci U S A (1988) 1.38
beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain. J Immunol (1994) 1.38
Inflammatory changes parallel the early stages of Alzheimer disease. Neurobiol Aging (2006) 1.37
Activated caspase-3 expression in Alzheimer's and aged control brain: correlation with Alzheimer pathology. Brain Res (2001) 1.36
Changes in the use of radiotherapy in Ontario 1984-1995. Int J Radiat Oncol Biol Phys (1999) 1.36
Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease. Neurobiol Aging (1997) 1.36
Mannose-binding lectin regulates the inflammatory response of human professional phagocytes to Neisseria meningitidis serogroup B. J Infect Dis (2001) 1.35
Correlation between caspase activation and neurofibrillary tangle formation in Alzheimer's disease. Am J Pathol (2001) 1.35
Conformationally defined neurotransmitter analogues. Selective inhibition of glutamate uptake by one pyrrolidine-2,4-dicarboxylate diastereomer. J Med Chem (1991) 1.35
Surface determinants of neuronal survival and growth on self-assembled monolayers in culture. Brain Res (1993) 1.34
Short-term exercise in aged Tg2576 mice alters neuroinflammation and improves cognition. Neurobiol Dis (2008) 1.32
Evolution in the conceptualization of dementia and Alzheimer's disease: Greco-Roman period to the 1960s. Neurobiol Aging (1998) 1.31
Glutamate as a CNS transmitter. I. Evaluation of glucose and glutamine as precursors for the synthesis of preferentially released glutamate. Brain Res (1979) 1.31
Identification of glycoproteins and proteins at synapses in the central nervous system. J Biol Chem (1977) 1.29
Synapse replacement in the nervous system of adult vertebrates. Physiol Rev (1981) 1.29
Proteins of the postsynaptic density. J Cell Biol (1974) 1.27
Brain injury causes a time-dependent increase in neuronotrophic activity at the lesion site. Science (1982) 1.26
Identification of types of cells in human peripheral blood that bind C1q. J Immunol (1981) 1.25
Learning ability in aged beagle dogs is preserved by behavioral enrichment and dietary fortification: a two-year longitudinal study. Neurobiol Aging (2005) 1.24
Identification of a protein related to tubulin in the postsynaptic density. Proc Natl Acad Sci U S A (1977) 1.24
Chordoma: the results of megavoltage radiation therapy. Int J Radiat Oncol Biol Phys (1983) 1.23
Trophic effects of interleukin-4, -7 and -8 on hippocampal neuronal cultures: potential involvement of glial-derived factors. Brain Res (1993) 1.23
Degeneration of hippocampal CA3 pyramidal cells induced by intraventricular kainic acid. J Comp Neurol (1980) 1.23
Thrombin receptor activation protects neurons and astrocytes from cell death produced by environmental insults. J Neurosci (1995) 1.22